Karin Dorinda Norlin Rodland (born 1949) is an American cancer cell biologist. She is a professor emeritus at Oregon Health and Science University.
Rodland earned an A.B. from Hood College in 1970, and a PhD in biology from Syracuse University in 1974. She also completed her post-doctoral research at Syracuse with a National Cancer Institute Public Health Service Research Service Award.
Rodland began her academic career at Reed College in 1979, then Oregon Health and Science University School of Medicine in 1985. She was named a laboratory fellow at the U.S. Pacific Northwest National Laboratory, and a professor emeritus in Cell, Developmental and Cancer Biology, at Oregon Health and Science University School of Medicine. She retired in June 2020.
Rodland serves on the board of directors for the U.S. Human Proteome Organization, the editorial board of Cancer Biomarkers and Cancer Genomics and Proteomics, and on the Leadership Development Committee of the Federation of American Societies for Experimental Biology. She was appointed to the Board of Directors of the Andy Hill Cancer Research Endowment (CARE) Fund by Washington State Governor Jay Inslee in 2022 and served through June 2024.